Implanting the enVista IOL

Show Description +

The enVista (Bausch + Lomb, Rochester, New York) is the first hydrophobic acrylic IOL to receive the FDA labeling claim of being 100% glistening-free. This lens combines the company's aspheric, aberration-free Advanced Optics technology with a new glistening-free material. It is intended to minimize posterior capsular opacification.

Posted: 10/31/2011

Implanting the enVista IOL

The enVista (Bausch + Lomb, Rochester, New York) is the first hydrophobic acrylic IOL to receive the FDA labeling claim of being 100% glistening-free. This lens combines the company's aspheric, aberration-free Advanced Optics technology with a new glistening-free material. It is intended to minimize posterior capsular opacification.

Posted: 10/31/2011

Please log in to leave a comment.

More in Cataract

Optimizing the Ocular Surface Before Surgery

Kendall E. Donaldson, MD, MS, and Gary Wörtz, MD

Practice Impossible: Real-World Case Conundrums

Eva Kim, MD, and Steven J. Dell

enVista Envy in Practice: A Surgeon to Surgeon Discussion

William F. Wiley, MD; and Steven J. Dell, MD